The Turkish Competition Authority re-evaluates a complaint of abuse of dominant position in the pharmaceutical sector upon the annulment of the State Council’s decision (Roche)

The Turkish Competition Board (hereinafter referred to as “CB”) had re-evaluated the allegations about the abuse of dominant position by Roche Mustahzarları A.S. (hereinafter referred to as “Roche”), upon the annulment decision of the 13th Chamber of the State Council numbered 31.03.2008 and numbered 2006/3795 P, 2008/3413 D. on CB's previous decision numbered 06-32/396-M, dated May 4, 2006 [1] . In the complaints against Roche, it was alleged that Roche was preventing the pharmaceutical warehouses other then Beser Ecza Deposu (hereinafter referred to as “Beser”) from entering into the Social Security Institutions (hereinafter referred to as “SSI”) tenders on the biotech goods and was further violating the competition legislation by partitioning the market, fixing prices and discriminating

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Ercüment Erdem, The Turkish Competition Authority re-evaluates a complaint of abuse of dominant position in the pharmaceutical sector upon the annulment of the State Council’s decision (Roche), 30 October 2008, e-Competitions October 2008, Art. N° 23818

Visites 1925

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues